EP3324956
ENANTIOMERS OF TETRAHYDRO-N,N-DIMETHYL-2,2-DIPHENYL-3-FURANMETHANAMINE (ANAVEX2-73) AND USE THEREOF IN THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER DISORDERS MODULATED BY THE SIGMA 1 RECEPTOR
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
19.7.2016EP published:
20.11.2024EP application number:
16827322.5
EPO information:
European Patent Register
Max expiry date:
18.7.2036
Title in English:
ENANTIOMERS OF TETRAHYDRO-N,N-DIMETHYL-2,2-DIPHENYL-3-FURANMETHANAMINE (ANAVEX2-73) AND USE THEREOF IN THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER DISORDERS MODULATED BY THE SIGMA 1 RECEPTORLanguage of the patent:
English
Timeline
Today
19.7.2016EP application
20.11.2024EP Publication
Owner
Name:
Anavex Life Sciences Corp.Address:
51 West 52nd Street 7th Floor, New York, NY 10019, US
Inventor
Name:
NELIAT, GervaisAddress:
New York, NY 10019, US
Priority
Number:
201562195417 PDate:
22.7.2015Country:
US
Classification
Categories:
A61K 31/341, A61P 25/28, C07D 307/14, G01N 33/567